SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Transgene Biotek informs about closure of trading window

28 Jun 2024 Evaluate

Transgene Biotek has informed that, pursuant to SEBI (Prohibition of Insider trading) Regulation, 2015 read with the Company's Insider Trading Policy including Code of Conduct for regulating, monitoring and reporting of trading by designated persons and their immediate relatives, the Trading Window for dealing in the shares of the Company is closed with effect from July 1, 2024 till 48 hours after the declaration of un-audited financial results of the Company for the first quarter ended June 30, 2024. The date of Board Meeting for the consideration of un-audited financial results of the Company for the quarter ended June 30, 2024 shall be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.10 0.22 (7.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×